Satoshi Ōmura

From WikiMD's WELLNESSPEDIA

Satoshi Ōmura (大村 智, Ōmura Satoshi, born July 12, 1935) is a Japanese biochemist specializing in pharmacology. He is known for the discovery and development of various pharmaceuticals originally occurring in microorganisms. In 2015, he was awarded the Nobel Prize in Physiology or Medicine jointly with William C. Campbell and Youyou Tu for their discoveries concerning a novel therapy against infections caused by roundworm parasites. More precisely, Campbell and Ōmura were awarded for their discoveries concerning a novel therapy against infections caused by roundworm parasites.

Early life and education[edit]

Ōmura was born in Yamanashi Prefecture, Japan, in 1935. He graduated from the University of Yamanashi, he went on to obtain a Master's degree in Science from Tokyo University of Science and a PhD in Pharmaceutical Sciences from the University of Tokyo and a PhD in Chemistry at the Tokyo University of Science.

Career and research[edit]

Ōmura has been a professor at Kitasato University since 1975 and is emeritus professor at Wesleyan University in the United States. He is known for the discovery and development of various pharmaceuticals originally occurring in microorganisms. His most notable discovery is Ivermectin, a drug that has radically lowered the incidence of River blindness and Lymphatic filariasis. He has also established a culture method for Streptomyces, which produce Streptomycin, the first antibiotic remedy for tuberculosis.

Awards and honors[edit]

In 2015, he was awarded the Nobel Prize in Physiology or Medicine jointly with William C. Campbell and Youyou Tu for their discoveries concerning a novel therapy against infections caused by roundworm parasites. He is also a recipient of the Japan Academy Prize and the Prince Mahidol Award.

Personal life[edit]

Ōmura is a keen amateur entomologist, specialized in scarab beetles.

See also[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.